Immunic, Inc. (IMUX)

NASDAQ: IMUX · Real-Time Price · USD

0.6790

-0.0329 (-4.62%)

At close: Dec 1, 2025, 4:00 PM EST

0.6804

+0.0014 (0.21%)

After-hours: Dec 1, 2025, 7:53 PM EST

Immunic Employees

Immunic had 91 employees as of December 31, 2024. The number of employees increased by 14 or 18.18% compared to the previous year.

Employees

91

Change (1Y)

14

Growth (1Y)

18.18%

Revenue / Employee

n/a

Profits / Employee

-$1,132,385

Market Cap

81.67M

Employees Chart

Employees History

Date	Employees	Change	Growth
Dec 31, 2024	91	14	18.18%
Dec 31, 2023	77	11	16.67%
Dec 31, 2022	66	11	20.00%
Dec 31, 2021	55	27	96.43%
Dec 31, 2020	28	2	7.69%
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro

Related Stocks

Company Name	Employees
UnitedHealth Group	400,000
Johnson & Johnson	138,100
Thermo Fisher Scientific	125,000
Abbott Laboratories	114,000
AstraZeneca	92,900
Novo Nordisk	77,349
Novartis AG	75,883
Merck & Co.	75,000

Employee Rankings

IMUX News

5 days ago - Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - PRNewsWire
18 days ago - Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
4 weeks ago - Immunic to Participate in Industry and Investor Conferences in November - PRNewsWire
2 months ago - Immunic to Participate in Scientific and Investor Conferences in October - PRNewsWire
2 months ago - Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS, Highlighting Its Potential in Multiple Sclerosis - PRNewsWire
2 months ago - Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis - PRNewsWire
3 months ago - Immunic to Participate in Investor and Scientific Conferences in September - PRNewsWire
4 months ago - Immunic (IMUX) Q2 Loss Widens 25% - The Motley Fool